Abstract:Objective: Primary adrenal lymphoma (PAL) is a rare form of adrenal mass. We summarize our experience in its clinical presentation, biochemical indexes, radiological features, pathological information, therapy regimens, and outcomes. Methods: This was an institutional review board-approved retrospective review of medical records and surgical pathology specimens of patients with a diagnosis of PAL at the Chinese People's Liberation Army General Hospital and the First Affiliate Hospital of Xiamen University between July 2007 and July 2017. Results: Twenty-six patients were identified. The mean age at presentation was 60.84 ± 13.14 years with a male-to-female ratio of 2.25:1 (18:8). The most common presenting symptoms were loss of appetite (65%, 17/26), weight loss (62%, 16/26), abdominal pain (58%, 15/26), and fatigue (58%, 15/26). The levels of lactate dehydrogenase (75%, 15/20), β2-microglobulin (100%, 10/10), C-reactive protein (82%, 14/17), and ferritin (88%, 7/8) and the erythrocyte sedimentation rate (83%, 10/12) were elevated. Bilateral involvement was seen in 21 of 26 patients (81%); 12 of 19 evaluated patients with bilateral lesions (63%) were confirmed to have adrenal insufficiency. On computed tomography (CT), the mean tumor diameter was 7.31 ± 3.35 cm and the median Hounsfield density was 37.0 HU (range: 31.0-45.0 HU); 67% (10/15) and 27% (4/15) of lesions presented with mild and moderate enhancement after injection of contrast medium. 18F-fluorodeoxyglucose positron emission tomography (FDG PET)-CT revealed not only an adrenal tumor but also extra-adrenal lesions. Diffuse large B-cell lymphoma (DLBCL) was the most common phenotype (92%, 24/26). Ninety-two percent (24/26) of patients received chemotherapy while 8% (2/26) received unilateral adrenalectomy plus chemotherapy. The prognosis of PAL was poor, with a general survival time of 7.20 ± 5.18 months. Conclusion: PAL is a rare disease. The clinical characteristics of PAL include loss of appetite and weight loss. Endocrine evaluation should be performed to determine whether patients have adrenal insufficiency, especially patients with bilateral lesions. FDG-PET appears to be more accurate than other imaging modalities in revealing extra-adrenal sites. Better therapy is required to improve the poor prognosis of PAL.

Primary Adrenal Lymphoma: Radiological; Pathological, Clinical Correlation.

Primary lymphomas in the brain: MR findings

CT Manifestations and Pathological Features of Primary Adrenocortical Carcinoma

CT and MR Imaging of Secondary Adrenal Lymphoma

Differential diagnosis of adrenal metastasis and lipid-poor adrenal adenoma with CT

CT and MRI Features of Primary Adrenal Lymphoma

Value of dual-phase contrast-enhanced MSCT in qualitative diagnosis of adrenal nodules in patients with malignant tumor

Adrenal Lymphoma:The Findings of Dynamic CT and MR

Primary diffuse large B-cell lymphoma of adrenal gland: A case report

CT Findings of Primary Adrenocortical Carcinoma

An Evaluation of MRI in the Diagnosis of Primary Adrenal Tumors

MRI diagnosis and differential diagnosis of primary adrenal cortical carcinoma

Adrenal schwannoma: CT, MR manifestations and pathological correlation.

Bilateral Primary Adrenal Diffuse Large B Cell Lymphoma Without Adrenal Insufficiency: A Case Report and Review of the Literature.

Primary adrenal lymphoma: three cases report and review of the literature

[A Clinical Analysis of 21 Cases of Adrenal Non-Hodgkin's Lymphoma].

Primary Adrenal Lymphoma: Two Case Series From China

Primary Pulmonary Lymphoma: CT Findings in 13 Cases

Primary adrenal diffuse large B cell Lymphoma with Tumor thrombus in central adrenal vein: a case report and literature review

Research on the evaluation of CT and MRI diagnosis in the large primary nonfunctional adrenal tumors

CT and MR imaging characteristics of primary hepatic lymphoma